国外注册号是在临床试验启动以后才申请的是不是就不能发SCI了？

近日，有客户询问国外注册号是在临床试验启动以后才申请的，据说这样就不能发SCI了，想请教一下是不是有这个情况和要求，下面艾德思小编为你带来专业的解答。

艾德思科研专家解答

专家原文解答是英文，为了防止用户看不懂，小编特意简单翻译整理了下。

1.一般情况下，临床试验注册号是在临床试验启动之前或在试验进行过程中申请的。

2. 虽然有些期刊可能要求在投稿时提供临床试验注册号，但并非所有期刊都有此要求。每个期刊要求不同。

另外 如果某个期刊对于临床试验注册号有特定的要求，客户可以在投稿之前查阅该期刊的投稿指南或联系期刊编辑，以了解其具体要求。

原文：

1. Most of the reputable medical and scientific journals have specific requirements concerning the timing of clinical trial registration for studies to be considered eligible for publication. These requirements are often in line with the guidelines set by organizations like the International Committee of Medical Journal Editors (ICMJE) and the World Health Organization (WHO). Generally, for a clinical trial to be eligible for publication in these journals, it is required that the trial be registered in a public clinical trials registry before the enrollment of the first patient. Hence, the registration number should be obtained and the trial registered before the actual initiation of the clinical trial, including the recruitment of any participants.

2. The flexibility of journals regarding the timing of clinical trial registration can vary based on the specific journal's policies and the nature of the study. Some journals might be more lenient in their requirements, others may strictly adhere to the principle of prospective trial registration. Hence, the flexibility of journals regarding trial registration timing is determined by their specific editorial policies and adherence to international guidelines.It is necessary to refer to the individual journal's author guidelines or policies to understand their stance on trial registration and flexibility. In case of any uncertainty, it is better to contact the journal's editorial office for clarification before submitting the manuscript.

3. When seeking publication in medical SCI journals for their gynecology-related research, there are several important considerations and recommendations to increase their chances of successful publication:For instance, it is of great importance to select an appropriate journal for their research and consider factors such as the journal's scope, impact factor, audience, and the types of articles published. Each journal has specific author guidelines that outline the formatting and submission requirements. It is required to carefully read and follow the journal's guidelines to avoid potential delays or rejections due to non-compliance. Additionally, it is necessary to ensure that their research complies with ethical standards, including obtaining informed consent from participants, following institutional review board approvals, and disclosing any conflicts of interest. Furthermore, the authors should follow the appropriate reporting guidelines for your study design. For example, randomized controlled trials should adhere to CONSORT guidelines, while observational studies should follow STROBE guidelines.

Hope this clarifies their doubts and concerns about clinical trial registration before publishing in a medical SCI journal. Thank you.

以上就是小编为你带了的关于国外注册号是在临床试验启动以后才申请的是不是就不能发SCI了的问题解答了，希望对你有所帮助！

本文由艾德思原创，未经许可授权，请勿转载。